Oral Rapamycin (Low-Dose)
Rapamycin (Sirolimus) 1-6 mg oral tablets
A low-dose sirolimus protocol that may be discussed off-label for selected patients. This use is not FDA-approved for longevity or healthy aging.
Legacy treatment library entry
This page is educational. The active Varus flow starts with labs or uploaded results, then moves into clinician review and a care plan before treatment checkout is shown.
What to know
Low-dose oral rapamycin has attracted interest in aging-biology circles because of preclinical work involving mTOR signaling. That does not mean it is FDA-approved for longevity, healthspan, or preventive use in otherwise healthy adults.
If clinicians discuss low-dose oral rapamycin, they do so only as an off-label conversation with clear disclosure that human longevity data is limited, that monitoring may be required, and that not every patient is an appropriate candidate.
How this option is discussed
Rapamycin inhibits mTOR signaling, a pathway frequently studied in aging biology and metabolism. Those mechanistic observations do not establish lifespan extension, broad immune benefit, or metabolic improvement in humans using low-dose off-label protocols.
What happens after this library page
Diagnostics-led review
This library entry points into a program, lab review, or upload-labs workflow rather than direct product checkout.
Clinician assessment
A clinician reviews symptoms, medical history, medications, contraindications, and any uploaded or ordered lab results.
Care plan first
Treatment is discussed only after a care plan exists and the next step is clinically clear.
Follow-up and monitoring
Monitoring cadence, refill timing, and additional diagnostics depend on the care plan rather than the public library page.
Off-label longevity use disclosure
- Rapamycin is FDA-approved for other indications; use for longevity or healthy-aging goals is off-label.
- Human evidence for low-dose oral rapamycin in healthy-aging use remains limited.
- This approach may require clinician monitoring and is not appropriate for every patient.
Medical services are provided by independent licensed clinicians using the Varus platform. Varus does not provide medical advice, diagnosis, or treatment. Compounded medications are prepared by licensed pharmacies and are not FDA-approved. Individual results may vary. This information is for educational purposes and does not constitute medical advice.